DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast
- PMID: 19342456
- PMCID: PMC2703536
- DOI: 10.1210/en.2008-1630
DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast
Abstract
Proliferation in the nonpregnant human breast is highest in the luteal phase of the menstrual cycle when serum progesterone levels are high, and exposure to progesterone analogues in hormone replacement therapy is known to elevate breast cancer risk, yet the proliferative effects of progesterone in the human breast are poorly understood. In a model of normal human breast, we have shown that progesterone increased incorporation of 5-bromo-2'-deoxyuridine and increased cell numbers by activation of pathways involved in DNA replication licensing, including E2F transcription factors, chromatin licensing and DNA replication factor 1 (Cdt1), and the minichromosome maintenance proteins and by increased expression of proteins involved in kinetochore formation including Ras-related nuclear protein (Ran) and regulation of chromosome condensation 1 (RCC1). Progenitor cells competent to give rise to both myoepithelial and luminal epithelial cells were increased by progesterone, showing that progesterone influences epithelial cell lineage differentiation. Therefore, we have demonstrated that progesterone augments proliferation of normal human breast cells by both activating DNA replication licensing and kinetochore formation and increasing bipotent progenitor numbers.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2703536/bin/zee0070948410001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2703536/bin/zee0070948410002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2703536/bin/zee0070948410003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2703536/bin/zee0070948410004.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2703536/bin/zee0070948410005.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2703536/bin/zee0070948410006.gif)
Comment in
-
Finally! A model for progesterone receptor action in normal human breast.Endocrinology. 2009 Jul;150(7):2988-90. doi: 10.1210/en.2009-0383. Endocrinology. 2009. PMID: 19549883 Free PMC article. No abstract available.
Similar articles
-
BRCA1 Attenuates Progesterone Effects on Proliferation and NFκB Activation in Normal Human Mammary Epithelial Cells.J Mammary Gland Biol Neoplasia. 2019 Sep;24(3):257-270. doi: 10.1007/s10911-019-09431-5. Epub 2019 May 18. J Mammary Gland Biol Neoplasia. 2019. PMID: 31104199
-
Progesterone stimulates progenitor cells in normal human breast and breast cancer cells.Breast Cancer Res Treat. 2014 Feb;143(3):423-33. doi: 10.1007/s10549-013-2817-2. Epub 2014 Jan 7. Breast Cancer Res Treat. 2014. PMID: 24395108
-
Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast.Mol Cell Endocrinol. 2012 Sep 25;361(1-2):191-201. doi: 10.1016/j.mce.2012.04.010. Epub 2012 May 2. Mol Cell Endocrinol. 2012. PMID: 22580007
-
The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis.Breast Cancer Res. 2002;4(5):197-201. doi: 10.1186/bcr452. Epub 2002 Jul 24. Breast Cancer Res. 2002. PMID: 12223124 Free PMC article. Review.
-
Marker molecules of human endometrial differentiation can be hormonally regulated under in-vitro conditions as in-vivo.Hum Reprod Update. 1998 Sep-Oct;4(5):539-49. doi: 10.1093/humupd/4.5.539. Hum Reprod Update. 1998. PMID: 10027607 Review.
Cited by
-
A molecular toolbox to study progesterone receptor signaling.J Mammary Gland Biol Neoplasia. 2023 Nov 29;28(1):24. doi: 10.1007/s10911-023-09550-0. J Mammary Gland Biol Neoplasia. 2023. PMID: 38019315 Free PMC article.
-
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.Pharmacol Rev. 2023 Nov;75(6):1233-1318. doi: 10.1124/pharmrev.121.000436. Epub 2023 Aug 16. Pharmacol Rev. 2023. PMID: 37586884 Free PMC article. Review.
-
ERBB Receptors and Their Ligands in the Developing Mammary Glands of Different Species: Fifteen Characters in Search of an Author.J Mammary Gland Biol Neoplasia. 2023 May 23;28(1):10. doi: 10.1007/s10911-023-09538-w. J Mammary Gland Biol Neoplasia. 2023. PMID: 37219601 Free PMC article. Review.
-
Unexplored Functions of Sex Hormones in Glioblastoma Cancer Stem Cells.Endocrinology. 2022 Mar 1;163(3):bqac002. doi: 10.1210/endocr/bqac002. Endocrinology. 2022. PMID: 35023543 Free PMC article. Review.
-
Unique Transcriptomic Changes Underlie Hormonal Interactions During Mammary Histomorphogenesis in Female Pigs.Endocrinology. 2022 Mar 1;163(3):bqab256. doi: 10.1210/endocr/bqab256. Endocrinology. 2022. PMID: 34918063 Free PMC article.
References
-
- Howard BA, Gusterson BA 2000 Human breast development. J Mammary Gland Biology Neoplasia 5:119–137 - PubMed
-
- Ismail PM, Amato P, Soyal SM, DeMayo FJ, Conneely OM, O'Malley BW, Lydon JP 2003 Progesterone involvement in breast development and tumorigenesis—as revealed by progesterone receptor “knockout” and “knockin” mouse models. Steroids 68:779–787 - PubMed
-
- Clarke CL, Sutherland RL 1990 Progestin regulation of cellular proliferation. Endocr Rev 11:266–301 - PubMed
-
- Pike MC, Spicer DV, Dahmoush L, Press MF 1993 Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15:17–35 - PubMed
-
- Santen RJ 2003 Risk of breast cancer with progestins: critical assessment of current data. Steroids 68:953–964 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous